Abzena plc

Industry

  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Large Molecule
      • Antibodies
    • Gene Therapy, Cell Therapy
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
  • Contract Research Organization-CRO

Other Names/Subsidiaries

  • ADC Cascade
  • Antitope Ltd.
  • Astro Bidco Limited
  • Biologics Cascade
  • PacificGMP
  • PolyTherics, Ltd.
  • TCRS
  • WCAS XII-Astro, L.P.
  • Antitope
  • PolyTherics
  • The Chemistry Research Solution
  • Warwick Effect Polymers
See more in Biomedtracker

Latest on Abzena plc

Scrip

Novartis Eyes Broader Market As Pluvicto Hits Mark In Pivotal Second-Line mCRPC Trial

 
• By Ayisha Sharma

Novartis AG ’s Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has met the primary endpoint in a pivotal second-line prostate cancer trial, sparking plans for a US filing that could significantly boo

Scrip

Finance Watch: Venture Floodgates Open With New Funds, Dozens Of Rounds

 
• By Mandy Jackson and Kevin Grogan

The number of biopharmaceutical companies raising venture capital this year has far outpaced the number raising money in public offerings, with 126 venture rounds during the first quarter versus just

Scrip

Finance Watch: VC Enthusiasm For Biopharma Continues As 5AM Ventures Raises $750m

 
• By Mandy Jackson and Kevin Grogan

Venture capital investment in private biopharmaceutical companies seems to have kept up a strong pace in 2022 relative to investment in publicly traded drug developers, which have been challenged to r

Scrip

Deal Watch: Seagen Ups Presence In HER2-Positive Cancer Field With RemeGen Deal

 
• By Joseph Haas, Vibha Ravi, and Mandy Jackson

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Seagen, RemeGen Partner Outside Asia, E